The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $87.80

Today's change-1.94 -2.16%
Updated September 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $87.80

Today's change-1.94 -2.16%
Updated September 29 4:00 PM EDT. Delayed by at least 15 minutes.

DexCom Inc down (U.S.)$1.94

DexCom Inc closed sharply lower Thursday, dropping (U.S.)$1.94 or 2.16% to (U.S.)$87.80. Shares have lost 6.62% over the last five days, but have gained 7.20% over the last year to date. This security has underperformed the S&P 500 by 8.38% during the last year.

Key company metrics

  • Open(U.S.) $89.89
  • Previous close(U.S.) $89.74
  • High(U.S.) $89.98
  • Low(U.S.) $86.26
  • Bid / Ask(U.S.) $81.33 / (U.S.) $88.10
  • YTD % change+7.20%
  • Volume2,731,716
  • Average volume (10-day)980,509
  • Average volume (1-month)747,900
  • Average volume (3-month)898,607
  • 52-week range(U.S.) $47.92 to (U.S.) $96.38
  • Beta0.14
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.99
Updated September 29 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.16%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue137116131105
Total other revenue--------
Total revenue137116131105
Gross profit86759175
Total cost of revenue52414031
Total operating expense157135129148
Selling / general / administrative69626152
Research & development36322965
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-20-192-42
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-192-43
Income after tax-20-192-43
Income tax, total0--0--
Net income-20-192-43
Total adjustments to net income--------
Net income before extra. items-20-192-43
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-20-192-43
Inc. avail. to common incl. extra. items-20-192-43
Diluted net income-20-192-43
Dilution adjustment----0--
Diluted weighted average shares84828281
Diluted EPS excluding extraordinary itemsvalue per share-0.24-0.230.02-0.53
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.24-0.230.02-0.53